| Literature DB >> 31125138 |
Duo Xu1, Di Wu1, Meng Qin2,3, Lina R Nih1, Chaoyong Liu1,3, Zheng Cao1, Jie Ren1, Xiangjun Chen4, Zhanlong He5, Wenhai Yu5, Jiaoqiong Guan5, Suqin Duan5, Fang Liu1, Xiangsheng Liu6, Jesse Li7, Dushawn Harley7, Bin Xu1,8, Lihua Hou9, Irvin S Y Chen2, Jing Wen2, Wei Chen9, Sina Pourtaheri7, Yunfeng Lu1.
Abstract
The central nervous system (CNS) plays a central role in the control of sensory and motor functions, and the disruption of its barriers can result in severe and debilitating neurological disorders. Neurotrophins are promising therapeutic agents for neural regeneration in the damaged CNS. However, their penetration across the blood-brain barrier remains a formidable challenge, representing a bottleneck for brain and spinal cord therapy. Herein, a nanocapsule-based delivery system is reported that enables intravenously injected nerve growth factor (NGF) to enter the CNS in healthy mice and nonhuman primates. Under pathological conditions, the delivery of NGF enables neural regeneration, tissue remodeling, and functional recovery in mice with spinal cord injury. This technology can be utilized to deliver other neurotrophins and growth factors to the CNS, opening a new avenue for tissue engineering and the treatment of CNS disorders and neurodegenerative diseases.Entities:
Keywords: blood-brain barrier; central nervous system; nerve growth factors; neural regeneration; spinal cord injury
Mesh:
Substances:
Year: 2019 PMID: 31125138 DOI: 10.1002/adma.201900727
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849